UNIGE document Scientific Article
previous document  unige:33916  next document
add to browser collection

VIH/sida : une sélection des nouveautés les plus prometteuses en 2012

Vu, D L
Published in Revue médicale suisse. 2013, vol. 9, no. 369, p. 150-5
Abstract News related to HIV/AIDS was marked in 2012 both by emerging therapies, as well as by the changes management strategies. Therefore, we will discuss the crucial issue of when to start antiretroviral therapy, which appears to be more and more early. Furthermore, after the U.S. validation of the pre-exposure prophylaxis for individuals at high risk of HIV acquisition, prevention of HIV transmission has returned to the spotlight. Finally, we will review some promising novel molecules whose mechanisms of action, half-life or low dosage open the door to new treatment strategies.
Keywords Anti-Retroviral Agents/therapeutic useHIV Infections/drug therapy/prevention & controlHepatitis C/complications/drug therapyHumansPost-Exposure Prophylaxis
PMID: 23409658
Full text
Article (Published version) (644 Kb) - document accessible for UNIGE members only Limited access to UNIGE
Other version: http://rms.medhyg.ch/numero-369-page-150.htm
Research group VIH/SIDA (930)
(ISO format)
VU, D L et al. VIH/sida : une sélection des nouveautés les plus prometteuses en 2012. In: Revue médicale suisse, 2013, vol. 9, n° 369, p. 150-5. https://archive-ouverte.unige.ch/unige:33916

396 hits



Deposited on : 2014-01-30

Export document
Format :
Citation style :